Pediatrics, ISSN 0031-4005, 06/2017, Volume 139, Issue 6, p. 1
BACKGROUND: Acetylsalicylic acid (ASA) is part of the recommended treatment of Kawasaki disease (KD). Controversies remain regarding the optimal dose of ASA to...
Pediatrics | Aspirin | Intravenous administration | Adjustment | Abnormalities | Coronary artery | Risk reduction | Cardiovascular disease | Acetylsalicylic acid | Dosage | Institutions | Fever | Children & youth | Disease prevention | Confidence intervals | Kawasaki disease | Children | Mucocutaneous lymph node syndrome | Drug dosages
Pediatrics | Aspirin | Intravenous administration | Adjustment | Abnormalities | Coronary artery | Risk reduction | Cardiovascular disease | Acetylsalicylic acid | Dosage | Institutions | Fever | Children & youth | Disease prevention | Confidence intervals | Kawasaki disease | Children | Mucocutaneous lymph node syndrome | Drug dosages
Journal Article
Pediatrics, ISSN 0031-4005, 06/2017, Volume 139, Issue 6, p. e20170098
BACKGROUND: Acetylsalicylic acid (ASA) is part of the recommended treatment of Kawasaki disease (KD). Controversies remain regarding the optimal dose of ASA to...
ARTERY INVOLVEMENT | IMMUNOGLOBULIN | GAMMA-GLOBULIN | RISK | PEDIATRICS | Mucocutaneous Lymph Node Syndrome - drug therapy | Humans | Child, Preschool | Infant | Male | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Coronary Disease - prevention & control | Mucocutaneous Lymph Node Syndrome - complications | Immunoglobulins, Intravenous - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Prevention | Treatment outcome | Aspirin | Immunoglobulins | Kawasaki disease | Patient outcomes | Causes of | Development and progression | Dosage and administration | Drug therapy | Comparative analysis | Coronary heart disease
ARTERY INVOLVEMENT | IMMUNOGLOBULIN | GAMMA-GLOBULIN | RISK | PEDIATRICS | Mucocutaneous Lymph Node Syndrome - drug therapy | Humans | Child, Preschool | Infant | Male | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Coronary Disease - prevention & control | Mucocutaneous Lymph Node Syndrome - complications | Immunoglobulins, Intravenous - therapeutic use | Female | Retrospective Studies | Drug Therapy, Combination | Prevention | Treatment outcome | Aspirin | Immunoglobulins | Kawasaki disease | Patient outcomes | Causes of | Development and progression | Dosage and administration | Drug therapy | Comparative analysis | Coronary heart disease
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.